Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Classical hematology 1Breast 1

Conditions

Neoplasms 23Venous Thromboembolism 20Febrile Neutropenia 20Anemia 20Thrombocytopenia 15Myelodysplastic Syndromes 14Leukemia, Myeloid, Acute 14Lymphoma 12Leukemia 12Anemia, Refractory, with Excess of Blasts 10Anemia, Aplastic 10Colorectal Neoplasms 9Breast Neoplasms 8Anemia, Iron-Deficiency 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Anemia, Sickle Cell 7Neutropenia 6Multiple Myeloma 6Ovarian Neoplasms 5Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Hematologic Neoplasms 5Fanconi Anemia, Complementation Group D1 5Hemophilia A 4Chemotherapy-induced Thrombocytopenia 4Stroke 3Pulmonary Disease, Chronic Obstructive 3Parkinson Disease 3Osteoporosis 3Multiple Sclerosis 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hyperthyroidism × Classical hematology × Clear all
NCT01105923 2015-02-02

MAPLE

Brigham and Women's Hospital

Phase NA Unknown
140 enrolled
BreastClassical hematologyHead & Neck

Anemia, Sickle Cell, Asthma, Attention Deficit Disorder with Hyperactivity, Bone Diseases, Metabolic, Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Glaucoma, Heart Failure, Hemophilia A, Hypertension, Hyperthyroidism, Hypothyroidism, Myasthenia Gravis, Osteoporosis, Stroke, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡